EXCELLERATE BIOSCIENCE LIMITED Financials
- Company number
- 10228159Copy
Copy - Registered office
- Ng2 Business Park, 21 The Triangle, Nottingham NG2 1AE
- Incorporated
- 13/06/2016
Company snapshot
- Status
- Active
- Employees
- 31 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
43.89%vs 20242024: £1.93M
Total Assets
28.03%vs 20242024: £2.57M
Cash in Bank
1.12%vs 20242024: £1.63M
Total Liabilities
-19.23%vs 20242024: £646.80K
Employees
+7vs 20242024: 24
In 2025, EXCELLERATE BIOSCIENCE LIMITED reported net assets of £2.77M. The same filing shows total assets of £3.30M, cash in bank of £1.65M and total liabilities of £522.42K. Reported headcount was 31 in 2025. Net Assets rose from £1.93M in 2024 to £2.77M in 2025 (43.89%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
43.89%from £1.93M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures EXCELLERATE BIOSCIENCE LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+79.5%vs 2023+34% a year compound (CAGR)
Cash in Bank
+70.8%vs 2023+30.7% a year compound (CAGR)
Total Assets
+76.6%vs 2023+32.9% a year compound (CAGR)
Total Liabilities
+62.7%vs 2023+27.6% a year compound (CAGR)
Employees
+47.6%vs 2023+10Biggest increase
Net Assets+79.5%
£1.55M in 2023 to £2.77M in 2025
Every indicator Okredo holds for EXCELLERATE BIOSCIENCE LIMITED rose between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, with cash in bank, total assets, total liabilities and employee numbers climbing alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from EXCELLERATE BIOSCIENCE LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 84.15%2025
- Liabilities to total assets
- 15.85%2025
- Cash to liabilities
- 316.16%2025
- Cash to total assets
- 50.11%2025
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for EXCELLERATE BIOSCIENCE LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 576.92K | 912.99K | 1.55M | 1.93M | 2.77M |
| Total Assets£ | 941.58K | 1.31M | 1.87M | 2.57M | 3.30M |
| Cash in Bank£ | 635.54K | 846.40K | 967.07K | 1.63M | 1.65M |
| Total Liabilities£ | 364.66K | 396.88K | 321.04K | 646.80K | 522.42K |
| Employees | 12 | 16 | 21 | 24 | 31 |
EXCELLERATE BIOSCIENCE LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has EXCELLERATE BIOSCIENCE LIMITED filed financial statements?
Yes. Okredo holds filed figures for EXCELLERATE BIOSCIENCE LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
What net assets did EXCELLERATE BIOSCIENCE LIMITED report in 2025?
EXCELLERATE BIOSCIENCE LIMITED reported net assets of £2.77M for 2025. That compares with £1.93M in 2024, a change of 43.89%.
What total assets did EXCELLERATE BIOSCIENCE LIMITED report in 2025?
EXCELLERATE BIOSCIENCE LIMITED reported total assets of £3.30M for 2025. That compares with £2.57M in 2024, a change of 28.03%.
What cash in bank did EXCELLERATE BIOSCIENCE LIMITED report in 2025?
EXCELLERATE BIOSCIENCE LIMITED reported cash in bank of £1.65M for 2025. That compares with £1.63M in 2024, a change of 1.12%.
How many people does EXCELLERATE BIOSCIENCE LIMITED employ?
EXCELLERATE BIOSCIENCE LIMITED reported 31 employees in 2025, compared with 24 in 2024.
How have EXCELLERATE BIOSCIENCE LIMITED financials changed over the last 3 years?
Between 2023 and 2025, EXCELLERATE BIOSCIENCE LIMITED's net assets rose by 79.5%, cash in bank rose by 70.8%, total assets rose by 76.6% and total liabilities rose by 62.7%. Net assets compounded at 34% a year across the two years to 2025, from £1.55M to £2.77M. Reported headcount went from 21 in 2023 to 31 in 2025 (+10).
Which years of EXCELLERATE BIOSCIENCE LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.